Oral steroids in initial treatment of acute sciatica

Area of Science:

• Neurology
• Pharmacology
• Clinical Medicine

Background:

• Acute sciatica is commonly treated with prednisone by physicians aiming to accelerate recovery.
• Clinical evidence supporting early prednisone use for acute sciatica is limited.
• This study investigated the efficacy of early oral prednisone in acute sciatica recovery.

Purpose of the Study:

• To determine if early oral prednisone administration impacts recovery parameters in acute sciatica.
• To evaluate the effect of prednisone on pain, function, and return to work.
• To assess patient-reported outcomes and need for interventions.

Main Methods:

• A double-blind, placebo-controlled clinical trial was conducted.
• 27 patients with acute sciatica received either prednisone or placebo within one week of symptom onset.
• Follow-up assessments were performed over five months.

Main Results:

• No significant differences were observed in physical findings, medication use, or return-to-work rates between groups.
• Patients receiving prednisone showed statistically significant, albeit subtle, improvements in pain, mental well-being, and disability scores.
• A trend towards fewer epidural injections was noted in the prednisone group.

Conclusions:

• Early oral prednisone in acute sciatica did not significantly affect most studied recovery parameters.
• A slight, statistically significant improvement in pain, mental well-being, and disability was observed with prednisone.
• The study suggests a potential impact of oral steroids on other outcomes, but the small sample size limits definitive conclusions.